Tirzepatide is a synthetic peptide studied for its dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is widely investigated in metabolic, glucose-regulation, and energy-balance research.
Dual GIP & GLP-1 Research
Studied for its combined activity at GIP and GLP-1 receptor pathways.
Metabolic Signaling
Investigated in research examining metabolic signaling and energy-balance mechanisms.
Glucose Regulation Research
Used in experimental research exploring pathways involved in glucose-dependent signaling.
Incretin Pathway Research
Studied as a dual-receptor agonist in research involving incretin signaling and metabolic processes.
What tirzepatide is
Tirzepatide is characterised in the literature as a dual agonist, carrying activity at both the GIP and GLP-1 receptors. Both are class B G-protein-coupled receptors involved in incretin signalling, and both respond to nutrient intake — but they are distinct receptors with distinct distributions, which is why a dual agonist is studied as a different object from a GLP-1 agonist rather than as a stronger one.
The design question a dual agonist raises is about balance. Two receptors reached by one molecule means the ratio of activity between them is a property of the molecule, not something the researcher sets.
Handling and reconstitution
Standard lyophilised peptide handling applies. Keep the sealed vial cold and dark until it is used. Reconstitute by running bacteriostatic water slowly down the inside wall of the vial rather than firing it onto the powder cake, and let it dissolve without shaking — swirl gently if it needs help.
The concentration you end up with is set by how much water you add, not by the vial size. Our reconstitution calculator turns vial mass and water volume into a concentration and a syringe reading.
Storage
Sealed and lyophilised: refrigerated, protected from light. In solution: refrigerated, and treat time at room temperature as a cost. Avoid repeated freeze-thaw once reconstituted.
What ships, and what is on the certificate
The vial ships sealed as it was filled. Every compound in the catalogue is tested by an outside laboratory — Vanguard Laboratory in Olympia, Washington — and the certificate is published in full rather than summarised.
The certificate reports chromatographic purity by HPLC with the chromatogram visible, the measured quantity in milligrams, and an endotoxin result by LAL. Measured quantity usually reads slightly above the label, which is normal: fills are targeted high so every vial meets its stated content.
Frequently asked questions
How does tirzepatide differ from a single GLP-1 agonist?
It has activity at the GIP receptor as well as the GLP-1 receptor. The two are separate receptors with separate distributions, so the pharmacology is a balance between two signals rather than a larger amount of one.
What is the difference between this and a triple agonist?
A triple agonist adds glucagon receptor activity, which pulls in a different direction from the two incretin receptors. Our incretin guide works through why that makes it a genuinely different design.
How should it be reconstituted?
Add bacteriostatic water slowly down the inside wall of the vial, then let it dissolve without shaking. The reconstitution calculator will convert vial mass and water volume into a concentration and a syringe reading.
Does it come with a certificate of analysis?
Yes. Every compound is tested by an independent laboratory and the full certificate, chromatogram included, is published on the site rather than summarised.
Is this a medicine?
No. It is sold for in-vitro laboratory research use only. It is not a drug, supplement or cosmetic, and is not for human or veterinary use.
Reviews
There are no reviews yet.